Cleavage of phospholipase D1 by caspase promotes apoptosis via modulation of the p53-dependent cell death pathway

Cell Death and Differentiation

Volumn 15, Issue 11, 2008, Pages 1782-1793

  Jang, Y H ^a   Namkoong, S ^b   Kim, Y M ^b   Lee, S J ^a   Park, B J ^a   Min, D S ^a  

^a Pusan National University   (South Korea)

^b Kangwon National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; CASPASE; CHECKPOINT KINASE 2; PHOSPHOLIPASE D1; PROTEIN P53; SMALL INTERFERING RNA;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL CELL CULTURE; APOPTOSIS; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME DEGRADATION; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOPRECIPITATION; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SITE DIRECTED MUTAGENESIS; WESTERN BLOTTING; WILD TYPE;

AMINO ACID SEQUENCE; ANIMALS; APOPTOSIS; CASPASES; CELL LINE; DNA DAMAGE; HUMANS; MICE; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; PHOSPHOLIPASE D; THERMODYNAMICS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 54049158044     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2008.111     Document Type: Article

References (33)

1. Singer WD, Brown HA, Sternweis PC. Regulation of eukaryotic phosphatidylinositolspecific phospholipase C and phospholipase D. Annu Rev Biochem 1997; 66: 475-509.
2. Freyberg Z, Siddhanta A, Shields D. 'Slip, sliding away' phospholipase D and the Golgi apparatus. Trends Cell Biol 2003; 13: 540-546.
3. Colley WC, Sung TC, Roll R, Jenco J, Hammond SM, Altshuller Y et al Phospholipase D2, a distinct phospholipase D isoform with novel regulatory properties that provokes cytoskeletal reorganization. Curr Biol 1997; 7: 191-201.
4. Stuckey J, Dixon J. Crystal structure of a phospholipase D family member. Nat Struct Biol 1999; 6: 278-284.
5. Hammond SM, Altshuller YM, Sung TC, Rudge SA, Rose K, Engebrecht J et al. Human ADP-ribosylation factor-activated phosphatidylcholine-specific phospholipase D defines a new and highly conserved gene family. J Biol Chem 1995; 270: 29640-29643.
6. McDermott M, Wakelam MJ, Morris AJ. Phospholipase D. Biochem Cell Biol 2004; 82: 225-253.
7. Hanahan D, Weinberg R. The hallmarks of cancer. Cell 2000; 1 57-70.
8. Foster DA, Xu L. Phospholipase D in cell proliferation and cancer. Mol Cancer Res 2003; 1: 789-800.
9. Hui L, Abbas T, Pielak RM, Joseph T, Bargonetti J, Foster DA. Phospholipase D elevates the level of MDM2 and suppresses DNA damage-induced increases in p53. Mol Cell Biol 2004; 24: 5677-5686.
10. Kim J, Lee YH, Kwon TK, Chang JS, Chung KC, Min DS. Phospholipase D prevents etoposide-induced apoptosis by inhibiting the expression of early growth response-1 and phosphatase and tensin homologue deleted on chromosome 10. Cancer Res 2006; 66: 784-793.
11. Kwun HJ, Lee JH, Min DS, Jang KL. Transcriptional repression of cyclin-dependent kinase inhibitor p21 gene by phospholipase D1 and D2. FEBS Lett 2003; 544: 38-44.
12. Kam Y, Exton JH. Dimerization of phospholipase d isozymes. Biochem Biophys Res Commun 2002; 1: 375-380.
13. Cai D, Zhong M, Wang R, Netzer WJ, Shields D, Zheng H et al. Phospholipase D1 corrects impaired APP trafficking and neurite outgrowth in familial Alzheimer's disease-linked presenilin-1 mutant neurons. PNAS 2006; 103: 1936-1940.
14. Michael D, Oren M. The p53-Mdm2 module and the ubiquitin system. Semin Cancer Biol 2003; 1: 49-58.
15. Chehab NH, Malikzay A, Stavridi ES, Halazonetis TD. Phosphorylation of Ser-20 mediates stabilization of human p53 in response to DNA damage. Proc Natl Acad Sci USA 1999; 96: 13777-13782.
16. Unger T, Juven-Gershon T, Moallem E, Berger M, Vogt SR, Lozano G et al. Critical role for Ser20 of human p53 in the negative regulation of p53 by Mdm2. EMBO J 1999; 7: 1805-1814.
17. Shiloh Y. ATM and related protein kinases: Safeguarding genome integrity. Nat Rev Cancer 2003; 3: 155-168.
18. Kim SJ, Ju JW, Oh CD, Yoon YM, Song WK, Kim JH et al. ERK-1/2 and p38 kinase oppositely regulate nitric oxide-induced apoptosis of chondrocytes in association with p53, caspase-3, and differentiation status. J Biol Chem 2002; 277: 1332-1339.
19. Erster S, Mihara M, Kim RH, Petrenko O, Moll UM. In vivo mitochondrial p53 translocation triggers a rapid first wave of cell death in response to DNA damage that can precede p53 target gene activation. Mol Cell Biol 2004; 24: 6728-6741.
20. Dhanalakshmi S, Agarwal C, Singh RP, Agarwal R. Silibinin up-regulates DNA-protein kinase-dependent p53 activation to enhance UVB-induced apoptosis in mouse epithelial JB6 cells. J Biol Chem 2005; 21 20375-20383.
21. Martins LM, Kottke TJ, Kaufmann SH, Earnshaw WC. Phosphorylated forms of activated caspases are present in cytosol from HL-60 cells during etoposide-induced apoptosis. Blood 1998; 9: 3042-3049.
22. Martins LM, Mesner PW, Kottke TJ, Basi GS, Sinha S, Tung JS et al. Comparison of caspase activation and subcellular localization in HL-60 and K562 cells undergoing etoposide-induced apoptosis. Blood 1997; 11: 4283-4296.
23. Shimada K, Nakamura M, Ishida E, Kishi M, Yonehara S, Konishi N. c-Jun NH2-terminal kinase-dependent Fas activation contributes to etoposide-induced apoptosis in p53-mutated prostate cancer cells. Prostate 2003; 4: 265-280.
24. Higginbottom K, Jahnke U, Newland AC, Cotter FE, Allen PD. New alternative phosphorylation sites on the cyclin dependent kinase 1/ cyclin a complex in p53-deficient human cells treated with etoposide: possible association with etoposide-induced apoptosis. Apoptosis 2007; 10: 1847-1855.
25. Chatterjee D, Schmitz I, Krueger A, Yeung K, Kirchhoff S, Krammer PH et al. Induction of apoptosis in 9-nitrocamptothecin-treated DU145 human prostate carcinoma cells correlates with de novo synthesis of CD95 and CD95 ligand and down-regulation of c-FLIP(short). Cancer Res 2001; 19: 7148-7154.
26. Matkar S, Wrischnik L, Hellmann-Blumberg U. Sanguinarine causes DNA damage and p53-independent cell death in human colon cancer cell lines. Chem Biol Interact 2008; 1: 63-71.
27. Marchetti A, Cecchinelli B, D'Angelo M, D'Orazi G, Crescenzi M, Sacchi A et al. p53 can inhibit cell proliferation through caspase mediated cleavage of ERK2/MAPK. Cell Death Differ 2004; 11: 596-607.
28. Yim HS, Hwang IS, Choi J-S, Chun KH, Jin YH, Ham Y-M et al. Cleavage of Cdc6 by caspase-3 promotes ATM/ATR kinase-mediated apoptosis of HeLa cells. J Cell Biol 2006; 174: 77-88.
29. Steed PM, Clark KL, Boyar WC, Lasala DJ. Characterization of human PLD2 and the analysis of PLD isoform splice variants. FASEB J 1998; 12: 1309-1317.
30. Toledo F, Wahl GM. Regulating the p53 pathway: In vitro hypotheses, in vivo veritas. Nat Rev Cancer 2006; 12: 909-923.
31. Oh KJ, Lee SC, Choi HJ, Oh DY, Kim SC, Min DS et al. Role of phospholipase D2 in antiapoptotic signaling through increased expressions of Bcl-2 and Bcl-xL. J Cell Biochem 2007; 6: 1409-1422.
32. Ahn BH, Kim SY, Kim EH, Choi KS, Kwon TK, Lee YH et al. Transmodulation between phospholipase D and c-Src enhances cell proliferation. Mol Cell Biol 2003; 23: 3103-3115.
33. Min DS, Ahn BH, Rhie DJ, Yoon SH, Hahn SJ, Kim MS et al. Expression and regulation of phospholipase D during neuronal differentiation of PC12 cells. Neuropharmacology 2001; 41: 384-391.